Table I.
Microbial strains used in this study
| Type | Name and strain | Strain | Description | Abbreviation | Source/Origin |
|---|---|---|---|---|---|
| Bacteria | L. pneumophila | Lp02 | Clinical isolate, derivative of Philadelphia-1 strain | Lp | Michele Swansona |
| F. tularensis subsp. tularensis | Schu4 | Clinical isolate, Type A strain | Schu4 | Ohio/Laura Roseb | |
| F. tularensis subsp. holarctica | LVS | Attenuated live vaccine strain, Type B strain | LVS | Russia/Laura Roseb | |
| NY98 | Clinical isolate, Type B strain | NY98 | New York/Laura Roseb | ||
| F. novicida | Utah 112 | Environmental isolate, saltwater | Fn | BEI resources | |
| Amoebae | A. castellanii | Neff | Environmental isolate, soil | Ac30010 | ATCC 30010 |
| A. castellanii | n/a | Derivative of ATCC 30011 strain, isolated from yeast culture | Ac30234 | ATCC 30234 | |
| A. polyphaga | Puschkarew | Clinical isolate, human corneal scrapings | Ap | ATCC 30461 | |
| V. vermiformis | CDC-19 | Environmental isolate, hospital cooling tower drain | Vv | ATCC 50237 |
Note: ATCC = American Type Culture Collection, USA; BEI Resources = Biodefense and Emerging Infections Research Resources Repository, USA.
a
University of Michigan.
b
Center for Disease Control and Prevention, USA.